Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a Passover gift and support Jewish journalism. DONATE NOW
The Schmooze

Ralph Steinman Wins Posthumous Nobel

As a result of some unusual timing, the Nobel Prize for Medicine has been awarded posthumously to scientist Ralph M. Steinman. Steinman, a Canadian-born researcher who worked at Rockefeller University, died of pancreatic cancer on September 30, but word of his passing did not reach the Nobel Committee in Sweden before it announced the award today. The Nobel Committee does not grant posthumous awards.

Nobel secretary general Goran Hansson called this a “unique situation, because he died hours before the decision was made.” The panel will have to decide what to do with the prize money that would have gone to Steinman, but it will not name a substitute winner.

Steinman, originally from Montreal, was awarded the prize together with his colleagues Bruce Beutler of the United States and Jules Hoffmann of France for their work on tumor vaccines. Steinman was recognized for his seminal immunology work, including his discovery of dendric cells in the 1970s. Steinman, who died at age 68, had extended his own life by using a dendric-cell immunotherapy on himself after he was diagnosed four years ago with pancreatic cancer.

According to Alexis Steinman, the deceased researcher’s daughter, her father was unaware of the Nobel Committee’s impending decision to give him the award. “We are all so touched that our father’s many years of hard work are being recognized with a Nobel Prize. He devoted his life to his work and his family and he would be truly honored,” she said.

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.